Costs in medicine – the lesser of two evils

Journal Title: Central European Journal of Urology - Year 2014, Vol 67, Issue 3

Abstract

Author's reply.

Authors and Affiliations

Michał Andrzej Skrzypczyk, Jakub Dobruch

Keywords

Related Articles

The new horizons of pharmacotherapy. Unexpected pharmacological actions and a new therapeutic strategy of phosphodiesterase–5 inhibitors

Introduction Benign prostate hyperplasia and erectile dysfunction affect a significant subset of men. BPH and ED may have the same promoting conditions and are the strong predicting risk factors to each other. A signific...

What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?

patients diagnosed with either idiopathic detrusor overactivity (IDO) or neurogenic detrusor overactivity (NDO). Material and methods Retrospective case–notes review of patients who were converted from 300IU to 200IU Ona...

Management and follow up of extra–adrenal phaeochromocytoma

Introduction The prevalence of phaeochromocytoma (PCC) in patients with hypertension is 0.1–0.6% and about 10% of PCCs are detected in extra–adrenal tissue. The diagnosis and therapy of this rare disease detected as a re...

The incidence of postoperative ileus in patients who underwent robotic assisted radical prostatectomy

Introduction Our aim was to examine the incidence and risk factors of postoperative ileus among patients who underwent robot–assisted radical prostatectomy (RARP). Material and methods We retrospectively reviewed 239 pat...

Download PDF file
  • EP ID EP342738
  • DOI 10.5173/ceju.2014.03.art4
  • Views 32
  • Downloads 0

How To Cite

Michał Andrzej Skrzypczyk, Jakub Dobruch (2014). Costs in medicine – the lesser of two evils. Central European Journal of Urology, 67(3), 233-233. https://europub.co.uk/articles/-A-342738